Trial Profile
Pioglitazone and Risk of Bladder Cancer in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jan 2022
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms PROBE-PIO
- 23 Jan 2022 Status changed from recruiting to completed.
- 28 Jun 2021 Planned End Date changed from 1 Jul 2021 to 1 Oct 2021.
- 28 Jun 2021 Planned primary completion date changed from 1 May 2021 to 1 Oct 2021.